NCT03542838View on ClinicalTrials.gov

Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

July 12, 2018

Primary Completion Date

April 13, 2020

Study Completion Date

February 11, 2021

Conditions
Osteoarthritis, KneePain, Knee
Interventions
DRUG

Resiniferatoxin

Resiniferatoxin is a compound purified from natural sources.

DRUG

Saline

Saline is a normal physiological solution

Trial Locations (4)

33136

University of Miami/Sylvester Comprehensive Cancer Center, Miami

77004

Hermann Drive Surgical Hospital, Houston

90048

Snibbe Orthopedics, Los Angeles

02115

Brigham & Women's Hospital, Boston

All Listed Sponsors
lead

Sorrento Therapeutics, Inc.

INDUSTRY

NCT03542838 - Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis | Biotech Hunter | Biotech Hunter